Citation 100971

MORITA,M: NAKANISHI,H: MORITA,H: MIHASHI,S: ITOKAWA,H:. (1996). STRUCTURES AND SPASMOLYTIC ACTIVITIES OF DERIVATIVES FROM SESQUITERPENES OF ALPINIA SPECIOSA AND ALPINIA JAPONICA.. 44(8)

Citation Details

Title	STRUCTURES AND SPASMOLYTIC ACTIVITIES OF DERIVATIVES FROM SESQUITERPENES OF ALPINIA SPECIOSA AND ALPINIA JAPONICA.
Authors	MORITA,M: NAKANISHI,H: MORITA,H: MIHASHI,S: ITOKAWA,H:
Year	1996
Volume	44
Issue	8

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (4)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	SELINENE,GAMMA:	EQUIVOCAL
2	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	SELINENE,GAMMA:	ACTIVE
3	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	SELINENE,BETA:	INACTIVE
4	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	SELINENE,BETA:	EQUIVOCAL
5	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-11-OL,15-HYDROXY: ACETATE	ACTIVE
6	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-11-OL,15-HYDROXY: ACETATE	ACTIVE
7	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-4-ONE,15-NOR: 11-HYDROXY:	WEAK ACTIVITY
8	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-4-ONE,15-NOR: 11-HYDROXY:	ACTIVE
9	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-BETA-11-DIOL,4-EPI:	ACTIVE
10	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-BETA-11-DIOL,4-EPI:	WEAK ACTIVITY
11	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-4-ONE,15-NOR: 11-ACETOXY:	ACTIVE
12	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-4-ONE,15-NOR: 11-ACETOXY:	ACTIVE
13	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-11-OL,15-NOR: 4-BETA-HYDROXY: ACETATE	ACTIVE
14	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-11-OL,15-NOR: 4-BETA-HYDROXY: ACETATE	ACTIVE
15	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-BETA-11-DIOL,15-NOR:	WEAK ACTIVITY
16	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-BETA-11-DIOL,15-NOR:	ACTIVE
17	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-4-BETA-OL,15-NOR: 11-HYDROXY: ACETATE	ACTIVE
18	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-4-BETA-OL,15-NOR: 11-HYDROXY: ACETATE	ACTIVE
19	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-BETA-11-DIOL,15-NOR: DIACETATE	ACTIVE
20	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-BETA-11-DIOL,15-NOR: DIACETATE	ACTIVE
21	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMOL,DIHYDRO:	ACTIVE
22	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMOL,DIHYDRO:	WEAK ACTIVITY
23	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-11-15-DIOL	ACTIVE
24	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-11-15-DIOL	ACTIVE
25	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-11-OL,15-HYDROXY:	ACTIVE
26	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-11-OL,15-HYDROXY:	ACTIVE
27	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-4-ALPHA-OL,11-ACETOXY:	ACTIVE
28	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-4-ALPHA-OL,11-ACETOXY:	ACTIVE
29	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOMERIDIOL	ACTIVE
30	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOMERIDIOL	ACTIVE
31	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-11-OL,4-ALPHA-15-EPOXY:	WEAK ACTIVITY
32	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESM-11-OL,4-ALPHA-15-EPOXY:	ACTIVE
33	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-ALPHA-11-15-TRIOL	INACTIVE
34	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-ALPHA-11-15-TRIOL	WEAK ACTIVITY
35	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-BETA-11-15-TRIOL,4-EPI:	INACTIVE
36	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMA-4-BETA-11-15-TRIOL,4-EPI:	INACTIVE
37	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMANE,11-ACETOXY-4-ALPHA-15-EPOXY:	ACTIVE
38	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMANE,11-ACETOXY-4-ALPHA-15-EPOXY:	ACTIVE
39	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HINES-11-OL,1-ALPHA-10-ALPHA-EPOXY:	EQUIVOCAL
40	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HINES-11-OL,1-ALPHA-10-ALPHA-EPOXY:	EQUIVOCAL
41	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HINESA-10-ALPHA-11-DIOL	EQUIVOCAL
42	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HINESA-10-ALPHA-11-DIOL	EQUIVOCAL
43	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HINESOL,2-OXO:	INACTIVE
44	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HINESOL,2-OXO:	EQUIVOCAL

Alpinia speciosa (ZINGIBERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	NEROLIDOL	None
2	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	NEROLIDOL	ACTIVE
3	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	NEROLIDOL	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	HUMULENE EPOXIDE II	None
5	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	EUDESMOL,BETA:	None
6	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HUMULENE EPOXIDE II	ACTIVE
7	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HUMULENE EPOXIDE II	ACTIVE
8	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMOL,BETA:	EQUIVOCAL
9	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	EUDESMOL,BETA:	ACTIVE

Alpinia japonica (ZINGIBERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EUDESMOL,BETA:	None
2	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HUMULENE EPOXIDE II	None
3	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AGAROFURAN,DIHYDRO: 4-ALPHA-HYDROXY:	None
4	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,DIHYDRO: 4-ALPHA-HYDROXY:	EQUIVOCAL
5	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	AGAROFURAN,DIHYDRO: 4-ALPHA-HYDROXY:	ACTIVE

Atractylodes lancea (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	EUDESMOL,BETA:	None
2	Not specified	ISOLATION AND IDENTIFICATION OF	HINESOL	None
3	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HINESOL	ACTIVE
4	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	HINESOL	ACTIVE